Current Formulations Private Limited

Current Formulations Private Limited - pharma in Thattachavadi, Puducherry, India. FY 2026 financials & compliance.
CIN U24239PY1982PTC000190 Incorporated 19 February 1982 ROC Pondicherry HQ Thattachavadi, Puducherry, India
Active Private Limited Company pharma
Revenue · FY 2024
₹6.03 Lakh
▼ 2% YoY
Net profit · FY 2024
₹8,542
Net margin 1.4%
EBITDA · FY 2024
₹39,371
EBITDA margin 6.5%
Authorised capital
₹12 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Satisfied charges
₹12.1 Cr
No open charges
Company age
44 yrs
Est. 1982
Directors on board
2
As per MCA filings

About Current Formulations Private Limited

Data last updated:

Current Formulations Private Limited is a private limited company based in Thattachavadi, Puducherry, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 1982 and has been in existence for over 44 years.

The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24239PY1982PTC000190.

The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Agillavadivu Visweswaran and Visweswaran Malaikkolundumudaliar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.03 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹8,542 (net margin 1.4%) and EBITDA of ₹39,371 (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 20% over five years.

As per MCA filings, the company has satisfied charges of ₹12.1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239PY1982PTC000190
Registration Number 000190
Incorporation Date 19 February 1982
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Current Formulations Private Limited's registered office is in Thattachavadi, Puducherry. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Current Formulations Private Limited, buy the company report.

Comprehensive company report
Current Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Current Formulations Private Limited

FY 2025 filings available

Current Formulations Private Limited reported revenue of ₹6.03 Lakh (down 2% YoY) for FY 2024.

Revenue · FY 2024
₹6.03 Lakh ▼ 2%
Net profit · FY 2024
₹8,542 margin 1.4%
EBITDA · FY 2024
₹39,371 margin 6.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 6%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 47%
5 years · compounded
▲ 91%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹39,371
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8,542
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin6.5%
Net Profit Margin1.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Current Formulations Private Limited, buy the company report.

Board of directors of Current Formulations Private Limited

Current Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Agillavadivu VisweswaranDirector20 Aug 201016 Years 3 MonthsCurrent
Visweswaran MalaikkolundumudaliarDirector20 Aug 201016 Years 3 MonthsCurrent

Peer comparison

Current Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ordnc 2025 000035 U74900br2014ptc022894 Private Limited₹6.13 Lakh (FY 2020)Patna, Bihar, India
Hippocampus Health Care Private Limited₹6.11 Lakh (FY 2018)272.0%Bangalore, Karnataka, India
Medilexicon Pharmaceuticals Private Limited₹6.09 Lakh (FY 2024)23.0%Jaipur, Rajasthan, India
Nobel Enkem Private Limited₹6.08 Lakh (FY 2024)3.0%Patna, Bihar, India
1St Rate Pharma Private Limited₹6.05 Lakh (FY 2025)Thane, Maharashtra, India
Current Formulations Private Limitedthis company₹6.03 Lakh (FY 2024)₹8,5421.4%-2.0%Thattachavadi, Puducherry, India
Turquoise House of Design and Trading Private Limited₹6.02 Lakh (FY 2024)-2.0%Haryana, India
Medineutrina Private Limited₹6.01 Lakh (FY 2025)300.0%Nagpur, Maharashtra, India
Marpu Builders Limited₹6 Lakh (FY 2024)Secunderabad, Telangana, India
Medifirst Pharma Private Limited₹5.99 Lakh (FY 2021)Nashik, Maharashtra, India
Mahi Biotech Limited₹5.95 Lakh (FY 2025)-67.0%Budaun, Uttar Pradesh, India

To see the full peer comparison of Current Formulations Private Limited, buy the company report.

Auditor

Current Formulations Private Limited is audited by GANESAN AND COMPANY for the financial year 2022.

Auditor firmFinancial yearFirm registration number
GANESAN AND COMPANYFY 2022000859S

Shareholding

The shareholding of Current Formulations Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Current Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹12.1 Cr
Breakdown by lending institutions
Karnataka Bank Limited₹12.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Apr 200590005903Karnataka Bank Limited₹12.1 CrSatisfied

To see the full charge records of Current Formulations Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Current Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Current Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Current Formulations Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Mukesh Parsuram Patel ceased to be Director on 27 Aug 2010.

AGM
Current Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Current Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pondicherry.
Charges
A charge registered on 28 Apr 2005 via Charge ID 90005903 with Karnataka Bank Limited was fully satisfied on 21 Dec 2010.
Ceased
Mukesh Parsuram Patel ceased to be Director.
Ceased
Pankaj Krishnakant Patel ceased to be Director.
Appointed
Agillavadivu Visweswaran was appointed as Director.
Appointed
Visweswaran Malaikkolundumudaliar was appointed as Director.
Charges
A charge with Karnataka Bank Limited of Rs. 1,210.00 Lakh registered on 28 Apr 2005 with Charge ID 90005903 was modified on 22 Jul 2008.
Charges
A charge with Karnataka Bank Limited amounted to Rs. 1,210.00 Lakh with Charge ID 90005903 was registered on 28 Apr 2005.
Incorporation
19 Feb 1982
Current Formulations Private Limited was registered on 19 Feb 1982 with Roc Pondicherry & aged 44 years 9 months as per MCA records.

Frequently asked questions

Current Formulations is an active private limited company based in Thattachavadi, Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 1982 (44+ years old) and is registered under CIN U24239PY1982PTC000190.

Current Formulations has 2 current directors:

The latest financial statements of Current Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Current Formulations is U24239PY1982PTC000190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Current Formulations has 1 court case on record: 1 filed by the company.

Current Formulations was incorporated on 19 February 1982, making it 44+ years old. It is registered with the Registrar of Companies, Pondicherry.

The peers of Current Formulations by revenue are Ordnc 2025 000035 U74900br2014ptc022894 Private Limited, Hippocampus Health Care Private Limited, Medilexicon Pharmaceuticals Private Limited, Nobel Enkem Private Limited, 1St Rate Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).

Mukesh Parsuram Patel ceased to be Director on 27 Aug 2010. Pankaj Krishnakant Patel ceased to be Director on 27 Aug 2010. Agillavadivu Visweswaran was appointed as Director on 20 Aug 2010. Current Formulations has 4 board changes on record in total.

The registered office of Current Formulations is at B – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009.

Current Formulations operates in the pharma industry, in the drug formulation and development segment.

Current Formulations has no open charges and satisfied charges of ₹12.1 Cr as per latest MCA filings.